[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SU1459215A1 - Composition of polymeric diffusion matrix for transdermal administration of drugs - Google Patents

Composition of polymeric diffusion matrix for transdermal administration of drugs

Info

Publication number
SU1459215A1
SU1459215A1 SU4189829/05A SU4189829A SU1459215A1 SU 1459215 A1 SU1459215 A1 SU 1459215A1 SU 4189829/05 A SU4189829/05 A SU 4189829/05A SU 4189829 A SU4189829 A SU 4189829A SU 1459215 A1 SU1459215 A1 SU 1459215A1
Authority
SU
USSR - Soviet Union
Prior art keywords
composition
drugs
transdermal administration
drug
diffusion matrix
Prior art date
Application number
SU4189829/05A
Other languages
Russian (ru)
Inventor
А.Е. Васильев
Н.А. Платэ
М.М. Фальдштейн
И.Ш. Шварц
А.П. Титов
О.О. Максименко
В.Н. Тохмахчи
Л.Б. Малхазов
Р.Г. Оганов
В.И. Метелица
В.К. Пиотровский
Г.Э. Дуденас
И.И. Макаускас
А.П. Бертулис
Original Assignee
Всесоюзный Научно-Исследовательский Институт Биотехнологии
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Всесоюзный Научно-Исследовательский Институт Биотехнологии filed Critical Всесоюзный Научно-Исследовательский Институт Биотехнологии
Priority to SU4189829/05A priority Critical patent/SU1459215A1/en
Application granted granted Critical
Publication of SU1459215A1 publication Critical patent/SU1459215A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

FIELD: pharmacy. SUBSTANCE: invention provides the constant and increase of drug rate absorption through the skin up to 70 mcg/hr x 70 mkg/h·cm, increase of time duration of matrix up to 7 days and efficacy coefficient of drug up to 82% This effect is caused by matrix composition consisting of polyvinylpyrrolidone (molecular mass is 500-1500) (53-63 wt.-%), plasticizer polyethylene glycol with molecular mass 300-600 (24-35 wt.-%) and drug (1-23 wt.-%). EFFECT: enhanced quality of composition. 1 dwg, 4 tbl
SU4189829/05A 1986-12-30 1986-12-30 Composition of polymeric diffusion matrix for transdermal administration of drugs SU1459215A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU4189829/05A SU1459215A1 (en) 1986-12-30 1986-12-30 Composition of polymeric diffusion matrix for transdermal administration of drugs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU4189829/05A SU1459215A1 (en) 1986-12-30 1986-12-30 Composition of polymeric diffusion matrix for transdermal administration of drugs

Publications (1)

Publication Number Publication Date
SU1459215A1 true SU1459215A1 (en) 1995-11-20

Family

ID=60534411

Family Applications (1)

Application Number Title Priority Date Filing Date
SU4189829/05A SU1459215A1 (en) 1986-12-30 1986-12-30 Composition of polymeric diffusion matrix for transdermal administration of drugs

Country Status (1)

Country Link
SU (1) SU1459215A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007200799B2 (en) * 2000-07-07 2011-02-03 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
US10179096B2 (en) 2001-05-01 2019-01-15 Corium International, Inc. Hydrogel compositions for tooth whitening
US10238612B2 (en) 2009-01-14 2019-03-26 Corium International, Inc. Transdermal administration of tamsulosin
US10835454B2 (en) 2001-05-01 2020-11-17 Corium, Inc. Hydrogel compositions with an erodible backing member
US10869947B2 (en) 2001-05-01 2020-12-22 Corium, Inc. Hydrogel compositions

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007200799B2 (en) * 2000-07-07 2011-02-03 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
US10179096B2 (en) 2001-05-01 2019-01-15 Corium International, Inc. Hydrogel compositions for tooth whitening
US10835454B2 (en) 2001-05-01 2020-11-17 Corium, Inc. Hydrogel compositions with an erodible backing member
US10869947B2 (en) 2001-05-01 2020-12-22 Corium, Inc. Hydrogel compositions
US10238612B2 (en) 2009-01-14 2019-03-26 Corium International, Inc. Transdermal administration of tamsulosin

Similar Documents

Publication Publication Date Title
DK0724885T3 (en) Pernasal composition and pernasal preparation containing this
DE69230772D1 (en) Medicinal preparations for the treatment of onychomycoses
MX9206577A (en) PHARMACEUTICAL COMPOSITION TO INHIBIT THE GROWTH OF TUMOR CELLS
EP0164998A3 (en) Compositions and methods of enhancing transdermal and transmembrane penetration of topical and systemic agents
HU892559D0 (en) Process for the preparation of transdermal pharmaceutical composition suitable for systemic administration, containing deprenyl as active ingredient
KR910009242A (en) Sustained release compositions for treatment of periodontal disease
DE3766200D1 (en) L-DOPA CONTAINING MEDICINAL PRODUCT.
NO883229D0 (en) NEW BENZIMIDAZOLD DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATION CONTAINING SUCH DERIVATIVES.
DE69409518D1 (en) LOW POLYARMINE NUTRIENT AND / OR MEDICINE COMPOSITION AND THERAPEUTIC USE THEREOF
KR900007424A (en) Method of using N-acetylglucosamine as a cytoprotective agent and composition thereof
SU1459215A1 (en) Composition of polymeric diffusion matrix for transdermal administration of drugs
MD1360C2 (en) A fungicidal composition, process for control and revention of plants Oomycetes infection
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
AU6886987A (en) Veterinary compositions incorporating a water swellable polymer
KR880007068A (en) Use of 13-cis retinoic acid
GB1474424A (en) Pharmaceutical composition for treating diabetic ketoacidosis
WO1991015210A1 (en) Compositions comprising cytotoxic agent and permeation enhancers
ES8607728A1 (en) Drug combinations having synergistic effect
KR870010871A (en) Intraoperative Treatment of Basal Cell Carcinoma by Recombinant Human Alpha Interferon
KR910021238A (en) Keloid Remedy
KR900017599A (en) Pharmaceutical composition for tumor treatment
KR880000094A (en) Gastritis Treatment
KR870005642A (en) Mixture of Diflunisal and Tromethamine
JPS6456617A (en) Sustained release antipsychotic agent
KR890007737A (en) Anti-caking agents